The Effect of PAOPA, a Novel Allosteric Modulator of Dopamine D2 Receptors, on Signaling Proteins Following Sub-Chronic Administration in Rats.

Daya, Ritesh; Ho, Joella; Thomson, Sharon; Bhandari, Jayant; Mishra, Ram K

Daya, Ritesh; Ho, Joella; Thomson, Sharon; Bhandari, Jayant; Mishra, Ram K.

Afiliación

Daya R; Department of Psychiatry and Behavioral Neurosciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Ho J; Department of Psychiatry and Behavioral Neurosciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Thomson S; Department of Psychiatry and Behavioral Neurosciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Bhandari J; Department of Psychiatry and Behavioral Neurosciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Mishra RK; Department of Psychiatry and Behavioral Neurosciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.

Curr Mol Pharmacol ; 14(4): 469-476, 2021 10 25.

Article en En | MEDLINE | ID: mdl-32912130

Asunto(s)

Hormona Inhibidora de la Liberación de MSH; Receptores de Dopamina D2; Animales; Hormona Inhibidora de la Liberación de MSH/farmacología; Pirrolidinonas/farmacología; Ratas; Receptores de Dopamina D1; Receptores de Dopamina D2/metabolismo

Palabras clave

D2 receptor; ERK1.; GRK2; PAOPA; Schizophrenia; sub-chronic

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hormona Inhibidora de la Liberación de MSH / Receptores de Dopamina D2 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Curr Mol Pharmacol Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Emiratos Árabes Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google